









Mercado
/
Acciones
/
nasdaq-crmd
/

CorMedix Inc

CRMD

10.610USD

+0.070+0.66%

Cierre 10/15, 16:00（ET）Cotizaciones retrasadas 15 min

791.73MCap. mercado

15.48P/E TTM



CorMedix Inc

10.610

+0.070+0.66%

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de CorMedix Inc Compañía

CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.

Información de CorMedix Inc



Símbolo de cotizaciónCRMD

Nombre de la empresaCorMedix Inc

Fecha de salida a bolsaMar 25, 2010

Director ejecutivoMr. Joseph Todisco

Número de empleados64

Tipo de seguridadOrdinary Share

Fin del año fiscalMar 25

Dirección300 Connell Drive

CiudadBERKELEY HEIGHTS

Bolsa de valoresNASDAQ Global Market Consolidated

PaísUnited States of America

Código postal07922

Teléfono19085179500

Sitio Webhttps://cormedix.com/

Símbolo de cotizaciónCRMD

Fecha de salida a bolsaMar 25, 2010

Director ejecutivoMr. Joseph Todisco

Ejecutivos de CorMedix Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Joseph Todisco

Chief Executive Officer, Director

302.20K

Mr. Steven W. Lefkowitz

Independent Director

127.65K

-3.77%

Ms. Susan Blum

Chief Financial Officer

69.69K

Ms. Janet M. Dillione

Independent Director

53.47K

-31.86%

Ms. Erin Mistry

Executive Vice President, Chief Commercial Officer

29.12K

-54.14%

Mr. Gregory Scott (Greg) Duncan

Independent Director

13.33K

Mr. Robert Stewart

Independent Director

11.00K

-69.44%

Mr. Dan Ferry

IR Contact Officer

Dr. Alan William Dunton, M.D.

Independent Director

Ms. Elizabeth (Liz) Massonhurlburt

Chief Operating Officer

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Joseph Todisco

Chief Executive Officer, Director

302.20K

Mr. Steven W. Lefkowitz

Independent Director

127.65K

-3.77%

Ms. Susan Blum

Chief Financial Officer

69.69K

Ms. Janet M. Dillione

Independent Director

53.47K

-31.86%

Ms. Erin Mistry

Executive Vice President, Chief Commercial Officer

29.12K

-54.14%

Mr. Gregory Scott (Greg) Duncan

Independent Director

13.33K

Desglose de ingresos

FY2025Q2

FY2025Q1

FY2024

Sin datos

Por regiónUSD

Nombre

Ganancia

Proporción

United States

39.74M

0.00%

Por negocio

Por región

Sin datos

Estadísticas de accionistas

Actualizado: dom., 14 de sep

Accionistas

Tipos de accionistas

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

6.42%

Abdalkader (Shaibatalhamd Aymen)

6.22%

The Vanguard Group, Inc.

5.77%

Marshall Wace LLP

3.46%

Citadel Advisors LLC

2.30%

Otro

75.83%

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

6.42%

Abdalkader (Shaibatalhamd Aymen)

6.22%

The Vanguard Group, Inc.

5.77%

Marshall Wace LLP

3.46%

Citadel Advisors LLC

2.30%

Otro

75.83%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

22.74%

Investment Advisor/Hedge Fund

13.43%

Hedge Fund

8.73%

Individual Investor

7.55%

Research Firm

1.48%

Pension Fund

0.63%

Bank and Trust

0.28%

Venture Capital

0.06%

Insurance Company

0.03%

Otro

45.06%

Participación institucional



Actualizado: mié., 1 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

298

35.12M

47.05%

+4.14M

2025Q2

280

26.40M

35.51%

-7.69M

2025Q1

281

29.73M

44.27%

-179.25K

2024Q4

252

24.74M

40.82%

-30.08K

2024Q3

228

19.79M

34.25%

-1.78M

2024Q2

217

17.74M

32.28%

-4.09M

2024Q1

218

17.92M

32.60%

-5.73M

2023Q4

217

19.38M

35.35%

-2.82M

2023Q3

208

18.46M

33.68%

-3.54M

2023Q2

197

19.74M

38.10%

+6.18M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

4.80M

6.42%

+485.88K

+11.27%

Jun 30, 2025

Abdalkader (Shaibatalhamd Aymen)

4.65M

6.22%

+4.65M

Aug 08, 2025

The Vanguard Group, Inc.

4.31M

5.77%

+675.49K

+18.59%

Jun 30, 2025

Marshall Wace LLP

2.58M

3.46%

+2.35M

+1019.17%

Jun 30, 2025

Citadel Advisors LLC

1.71M

2.3%

+1.61M

+1517.64%

Jun 30, 2025

State Street Investment Management (US)

1.60M

2.15%

+62.52K

+4.06%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.60M

2.14%

+163.40K

+11.40%

Jun 30, 2025

Nuveen LLC

1.45M

1.94%

+1.27M

+740.45%

Jun 30, 2025

Alyeska Investment Group, L.P.

750.00K

+750.00K

Jun 30, 2025

Ghisallo Capital Management LLC

750.00K

+750.00K

Jun 30, 2025

ETFs relacionados



Actualizado: lun., 6 de oct

Nombre

Proporción

Invesco Dorsey Wright Healthcare Momentum ETF

2.14%

SPDR S&P Pharmaceuticals ETF

1.45%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

1.05%

First Trust Active Factor Small Cap ETF

0.44%

Janus Henderson Small Cap Growth Alpha ETF

0.32%

iShares Micro-Cap ETF

0.2%

Vanguard US Multifactor ETF

0.16%

Vanguard US Momentum Factor ETF

0.13%

Principal U.S. Small-Cap ETF

0.12%

Fidelity Small-Mid Multifactor ETF

0.12%

Invesco Dorsey Wright Healthcare Momentum ETF

Proporción2.14%

SPDR S&P Pharmaceuticals ETF

Proporción1.45%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

Proporción1.05%

First Trust Active Factor Small Cap ETF

Proporción0.44%

Janus Henderson Small Cap Growth Alpha ETF

Proporción0.32%

iShares Micro-Cap ETF

Proporción0.2%

Vanguard US Multifactor ETF

Proporción0.16%

Vanguard US Momentum Factor ETF

Proporción0.13%

Principal U.S. Small-Cap ETF

Proporción0.12%

Fidelity Small-Mid Multifactor ETF

Proporción0.12%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

